Angiogenesis in chronic hepatitis C is associated with inflammatory activity grade and fibrosis stage

Pathology Research and Practice

Volumn 205, Issue 11, 2009, Pages 758-764

  Gabriel, Andrzej ^a   Kukla, Michał ^a   Wilk, Mariusz ^a   Liszka, Łukasz ^a   Petelenz, Michał ^a   Musialik, Joanna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Angiogenesis; CD 34; Chronic hepatitis C; Fibrosis; Inflammatory activity

Indexed keywords

CD34 ANTIGEN;

ADULT; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN;

ADULT; ANTIGENS, CD34; FEMALE; FIBROSIS; HEPATITIS C, CHRONIC; HUMANS; INFLAMMATION; LIVER; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STATISTICS, NONPARAMETRIC;

EID: 71749091179     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.06.007     Document Type: Article

References (32)

1. Amarapurkar A.D., Amarapurkar A.N., Vibhav S., and Patel N.D. Angiogenesis in chronic liver disease. Ann. Hepatol. 6 3 (2007) 170-173
2. Bedossa P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20 (1994) 15-20
3. Bernardini G., Ribatti D., Spinetti G., Morbidelli L., Ziche M., Santoni A., et al. Analysis of the role of chemokines in angiogenesis. J. Immunol. Methods 273 (2003) 83-101
4. Carmeliet P., and Jain R. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
5. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
6. Chedid A., Arain S., Snyder A., Mathurin P., Capron F., and Naveau S. The immunology of fibrogenesis in alcoholic liver disease. Arch. Pathol. Lab. Med. 128 11 (2004) 1230-1238
7. Di Carlo I., Fraggetta F., Lombardo R., Azzarello G., Vasquez E., and Puleo S. Panminerva Med. 44 (2002) 365-367
8. Fernandez M., Semela D., Bruix J J., Colle I., Pinzani M., and Bosch J. Angiogenesis in liver disease. J. Hepatol. 50 (2009) 604-620
9. Garcia-Monzon C., Sanchez-Madrid F., Garcia-Buey L., García-Arroyo A., García-Sánchez A., and Moreno-Otero R. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108 (1995) 231-241
10. Hoofring A., Boitnott J., and Torbenson M. Three-dimensional reconstruction of hepatic bridging fibrosis in chronic hepatitis C viral infection. J. Hepatol. 39 (2003) 738-741
11. Hynes R.O. A reevaluation of integrins as mediators of angiogenesis. Nat. Med. 8 (2002) 918-921
12. Jackson C. Matrix metalloproteinases and angiogenesis. Curr. Opin. Nephrol. Hypertens. 11 3 (2002) 295-299
13. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9 (2003) 685-693
14. Kalluri R. Basement membrane: structure, assembly and role in tumor angiogenesis. Nat. Rev. Cancer 3 (2003) 422-433
15. Kukla M., Warakomska I., Gabriel A., Zwirska-Korczala K., Rybus-Kalinowska B., Berdowska A., et al. Serum levels of sICAM-1, TNFα, sTNF-R1, and sTNF-R2 in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin. Exp. Clin. Hepatol. 4 1 (2008) OR12-OR20
16. Lai W.K., and Adams D.H. Angiogenesis and chronic inflammation; the potential for novel therapeutic approaches in chronic liver disease. J. Hepatol. 42 1 (2005) 124-131
17. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., et al. Angipoietin-2, a natural antagonist for Tie-2 that disrupt in vivo angiogenesis. Science 277 (1997) 55-60
18. Mazzanti R., Messerini L., Monsacchi L., Buzzelli G., Zignego A.L., Foschi M., et al. CVH induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology 25 1 (1997) 229-234
19. Medina J., Arroyo A.G., Sanchez-Madrid F., and Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology 39 (2004) 1185-1195
20. Medina J., Caveda L., Sanz-Cameno P., Arroyo A.G., Martín-Vílchez S., Majano P.L., et al. Hepatocyte growth factor activates endothelial proangiogenic mechanism relevant in chronic hepatitis C-associated neoangiogenesis. J. Hepatol. 38 (2003) 660-667
21. Pinzani M., and Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21 (2001) 397-416
22. Salcedo X., Medina J., Sanz-Cameno P., García-Buey L., Martín-Vilchez S., Borque M.J., et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 42 (2005) 696-701
23. Salcedo-Mora X., Sanz-Cameno P., Medina J., Martín-Vílchez S., García-Buey L., Borque M.J., et al. Association between angiogenesis soluble factors and disease progression markers in chronic hepatitis C patients. Rev. Esp. Enferm. Dig. (Madrid) 97 (2005) 699-706
24. Scheuer P.J. The nomenclature of chronic hepatitis: time for a change. J. Hepatol. 22 (1995) 112-114
25. Simpson K.J., Henderson N.C., Bone-Larson C., Lukacs N.W., Hogaboam C.M., Kunkel S.L., et al. Chemokines in pathogenesis of liver disease: so many players with poorly defined roles. Clin. Sci. (London) 104 (2003) 47-63
26. Strauss L.C., Rowley S.D., LaRussa V.F., Sharkis S.J., Stuart R.K., Civin C.I., et al. Antigenic analysis of hematopoiesis. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol. 14 9 (1986) 878-886
27. Tanaka F., Otake Y., Yanagihara K., Kawano Y., Miyahara R., Li M., et al. Evaluation of angiogenesis in non-small cell lung cancer. Comparison between anti-CD34 and anti-CD105 antibody. Clin. Cancer Res. 7 (2001) 3410-3415
28. Vermeulen P.B., Gasparini G., Fox S.B., Toi M., Martin L., McCulloch P., et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer 32A 14 (1996) 2474-2484
29. Visconti R.P., Richardson C., and Sato T. Orchestration of angiogenesis and arteriovenous contribution by angipoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. USA 99 (2002) 8219-8224
30. Zwirska-Korczala K., Kukla M., Ziolkowski A., Janczewska-Kazek E., Berdowska A., Sitkiewicz A., et al. Leptin, neopterin and hepatocyte growth factor as markers of fibrosis and inflammatory activity in chronic hepatitis C. Exp. Clin. Hepatol. 1 2 (2005) OR60-OR65
31. Zwirska-Korczala K., Kukla M., Ziolkowski A., Janczewsaka-Kazek E., Rybus-Kalinowska B., Berdowska A., et al. Association of serum sVCAM-1 concentration with fibrosis stage and inflammatory activity grade in chronic hepatitis C patients. Exp. Clin. Hepatol. 2 2 (2006) OR60-OR64
32. Zwirska-Korczala K., Kukla M., Ziolkowski A., Janczewska-Kazek E., Berdowska A., Rybus-Kalinowska B., et al. The usefulness of sPECAM-1 (sCD 31) serum concentration measurement in chronic hepatitis, C. Exp. Clin. Hepatol. 2 2 (2006) OR55-OR59